Skip to main content

Table 3 Results of pulmonary function tests, HRCT alveolar and interstitial score of chronic EAA and sarcoidosis patients

From: R ole of interleukin 4 and its receptor in clinical presentation of chronic extrinsic allergic alveolitis: a pilot study

 

Chronic EAA

Sarcoidosis

p

FVC (% e.v.)

79,8 ± 17,8

86,2 ± 22,4

> 0,05

79 [55–121]

92,5 [42–101]

FEV1 (% e.v.)

84,0 ± 18,2

81,2 ± 19,9

> 0,05

81,5 [53–124]

87,5 [42–98]

Dl co (% e.v.)

47,9 ± 19,7

62,8 ± 17,5

< 0,05

42 [30–91]

55 [46–98]

HRCTa

1,7 ± 1,0

2 ± 1,6

> 0,05

1,5 [0–3]

2 [0–4]

HRCTi

1,9 ± 1,0

1,5 ± 1,3

> 0,05

 

2 [1-4]

1 [0–3]

 
  1. Dl co lung diffusing capacity for carbon monoxide, e.v. expected value, FEV 1 forced expired volume in 1 second, FVC forced vital capacity, HRCTa high resolution computed tomography alveolar score, HRCTi high resolution computed tomography interstitial score. Values are presented as mean ± SD/ median [min-max value].
Back to article page

Multidisciplinary Respiratory Medicine

ISSN: 2049-6958

Contact us